DogBreedCompass
← Back to breed profile

PRA-rcd3 and Reading a Shetland Sheepdog DNA Panel

Quick answer

Does a carrier result mean my dog is affected?

No. For a recessive condition, a carrier has one variant copy and will not develop the disease. It matters only for breeding decisions.

It was characterised in the Cardigan Welsh Corgi. Your Sheltie's DNA panel may still report on it, and that reporting needs interpreting rather than believing.

PRA-rcd3 and Reading a Shetland Sheepdog DNA Panel infographic

Owners who have opened a commercial DNA panel report and found a list of retinal conditions, and breeders trying to work out which results on that list should influence a mating and which are noise.

Important reminder

This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.

Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.

What this problem looks like

PRA-rcd3 is a specific early-onset retinal degeneration with a characterised gene variant, established in the Cardigan Welsh Corgi. For Shetland Sheepdog owners the practical issue is not the disease but the report: broad commercial DNA panels test this variant regardless of breed, and a carrier or affected result read without context causes considerable and usually unnecessary alarm. The real task is knowing which lines on a panel should change anything.

Common triggers

  • Running a broad commercial panel that tests variants characterised across all breeds
  • Reading the list of condition names without the accompanying breed-relevance annotation
  • Confusing carrier status with affected status for a recessive condition
  • Assuming a genetic prediction replaces a clinical eye examination
  • Encountering unfamiliar terminology at a moment of worry rather than with a vet

The misreading is common; the disease in this breed is not. Panels routinely report on more than a hundred conditions, so almost every dog tested returns at least one carrier result somewhere on the list. That is expected and usually meaningless, but it is presented in a format that does not always make it feel that way.

Why this happens

Breed factors

Shetland Sheepdogs have a specific and well-defined set of documented health conditions, and rcd3 is not among them. The breed's genuinely important genetic results are the Collie Eye Anomaly variant and, above all, MDR1 drug sensitivity, which alters drug handling for the whole of the dog's life. The breed's inclusion in the herding group is part of why panels flag so much: many variants have been characterised in collies, corgis, Australian Shepherds and shepherds, and a Sheltie sample gets tested against all of them.

Environment factors

This is a problem created by how information is delivered rather than by anything in the dog's surroundings. Direct-to-consumer testing sends results straight to owners without a clinician mediating them, and the reports are read at home, out of hours, by people who are worried. The structure of the report matters: a list of frightening condition names above the interpretive text will produce alarm regardless of what the interpretive text says.

What you can do at home (once it is not an emergency)

When to talk to your vet

A genetic report is never itself an emergency, and no result on a panel requires an out-of-hours call. Book a routine appointment to review the report and identify which findings are actionable, and bring the full document rather than a summary. Book promptly, within days, if your Sheltie has actual clinical signs regardless of what the panel said: hesitation in low light, bumping into things in unfamiliar places, or a change in the appearance of the eyes. Go the same day for sudden vision loss, a painful, red, cloudy or bulging eye, or an eye the dog is holding shut, since those represent conditions with a short treatment window and none of them are predicted by a DNA test.

At home, alongside your vet's plan

  • Find the breed-relevance annotation on your report before reading the condition names, since most laboratories mark which results apply to your dog's breed.
  • Check the inheritance mode for every flagged result, since a carrier of a recessive variant is not an affected dog under any circumstances.
  • Take the whole report to your vet and ask which two or three lines should change how the dog is managed.
  • Prioritise the targeted tests that matter in this breed, particularly MDR1, over a broad panel if budget is limited.
  • Keep the MDR1 result somewhere clinically visible: the practice record, your phone, and a note on the carrier.
  • Book an annual ophthalmologist examination regardless of what any panel said, because observation beats prediction for an individual dog.

See all Shetland Sheepdog health problems, which breeds are prone to progressive retinal atrophy pra rcd3, or the full Shetland Sheepdog breed guide for temperament, exercise needs and ownership costs.

What to expect, and how you know it is working

A DNA panel returns results in two to four weeks and the result never changes, since genotype is fixed for life. The useful timeline is therefore about interpretation rather than progression: one appointment to review the report with a vet is usually sufficient. Where actual retinal disease exists, that follows its own course over years and is monitored by annual examination rather than by retesting DNA.

Success is an owner who can look at a two-page panel report and correctly identify the one or two lines that matter, and who has the MDR1 result written where a clinician will see it. It is not a report with no flagged variants, which almost nobody gets. Being able to hold a carrier result calmly, and to keep booking the annual examination that would actually detect a problem, is the whole of the outcome here.

How to read a recessive result properly

Almost every variant reported on these panels is recessive, meaning two copies are required for disease. Understanding the three possible results removes most of the panic.

  • Clear, sometimes written as normal or homozygous normal. Two working copies. The dog cannot develop this condition and cannot pass the variant to its puppies.
  • Carrier, or heterozygous. One working copy and one variant copy. The dog will not develop the condition. It will pass the variant to about half its puppies, which matters only if bred.
  • Affected, or homozygous for the variant. Two variant copies. The dog is expected to develop the condition, though the panel cannot tell you when or how severely.
  • The breeding rule that follows: a carrier bred to a clear produces no affected puppies. A carrier bred to a carrier produces roughly a quarter affected. Carriers do not need removing from a gene pool, they need pairing carefully.
  • The interpretation rule that matters more: a variant characterised in one breed does not automatically cause disease in another. Panels test the variant, not the breed context.
  • And the practical rule: a DNA result is a prediction, an ophthalmologist's examination is an observation. For an individual dog's vision, the examination is what counts.

Which results actually matter for a Shetland Sheepdog

The Shetland Sheepdog's documented health conditions are Collie Eye Anomaly, MDR1 drug sensitivity, dermatomyositis, hypothyroidism and patellar luxation. That is the list that should shape how you read a panel report.

The two genuinely actionable genetic results in this breed are the Collie Eye Anomaly variant and the MDR1 variant. The first tells you about the breed's headline inherited eye disease. The second is arguably the most useful single test any Sheltie owner can have done, because it changes drug and anaesthetic decisions for the whole of the dog's life. If you only ever run one test, run that one.

Everything else on a broad panel should be read with the question: has this variant been established in Shetland Sheepdogs, or is the laboratory simply testing every variant it has an assay for? Commercial panels routinely report on well over a hundred conditions across all breeds, and the assay works regardless of which breed the sample came from.

That is not a criticism of the panels, which are transparent about it in their documentation and generally annotate breed relevance. It is a criticism of how the reports get read, usually at midnight, by an owner who has skipped to the list of scary-sounding names.

Bring the report to your vet, and ask which two or three lines on it should change anything.

PRA-rcd3 and Reading a Shetland Sheepdog DNA Panel - Which results actually matter for a Shetland Sheepdog
PRA-rcd3 and Reading a Shetland Sheepdog DNA Panel - Which results actually matter for a Shetland Sheepdog

The panel that flagged eleven things and mattered for one

Hanne ran a broad health panel on her two-year-old Sheltie, Juno, after seeing an advertisement. The report listed eleven variants where Juno was not clear, including a carrier result for an early-onset retinal condition she had never heard of. She spent a weekend convinced her dog was going blind. Her vet went through the report line by line at a routine appointment. Ten of the eleven were carrier results for recessive conditions, most characterised in breeds unrelated to hers, and none of them meant Juno would develop anything. The eleventh was MDR1. Juno was affected, with two copies of the variant, which meant she was fully drug sensitive. That result went onto the front of her clinical record, into Hanne's phone, and onto a tag on her collar. Eighteen months later Juno needed a dental. The practice chose the anaesthetic protocol around a genotype they already knew. Hanne's view is that she paid for eleven results and got value from one, but that one was worth the whole panel.

Key takeaway: A broad DNA panel will nearly always flag several variants, and nearly all of them will be carrier results for conditions from other breeds. Read for the two that matter in a Shetland Sheepdog, and act decisively on MDR1.

Frequently asked questions

My Sheltie panel says carrier for PRA-rcd3. Is my dog going blind?

No. A carrier of a recessive variant does not develop the condition, by definition. That is true regardless of which breed the variant was characterised in. The only implication of a carrier result is for breeding, and even that depends on whether the variant is relevant in Shetland Sheepdogs at all.

Which eye tests actually matter for this breed?

The Collie Eye Anomaly DNA test, and more importantly the ophthalmologist's examination of a litter at six to eight weeks, which is what identifies colobomas. Annual screening examinations in adults catch progressive changes that no DNA test predicts.

Why do panels test variants from other breeds?

Because the assay detects a specific piece of DNA sequence, and that assay works on any dog's sample. Laboratories run comprehensive panels because it is cheaper than customising per breed, and most annotate which results are considered relevant to your dog's breed. Those annotations are the part worth reading.

Should I avoid breeding from a carrier?

Generally no, and removing all carriers from a breed's gene pool can do more harm than the variant does, by narrowing genetic diversity. The standard approach is to breed carriers to clears, which produces no affected puppies, and to test the resulting litter so buyers know each puppy's status.

What does rcd3 do in the breeds where it is established?

It causes early-onset degeneration of the retina's light-sensing cells, with affected dogs showing vision problems within their first year rather than in middle age. It is a severe form precisely because it strikes so early, which is what makes an incorrect interpretation in an unaffected breed so alarming.

What is the single most useful DNA test for a Sheltie?

MDR1. It is inexpensive, done once, and it changes prescribing and anaesthetic decisions for the rest of the dog's life. Every Shetland Sheepdog should have the result recorded prominently in its clinical file whether or not any other testing is done.

Quick answers

View more answers
Health

Does a carrier result mean my dog is affected?

No. For a recessive condition, a carrier has one variant copy and will not develop the disease. It matters only for breeding decisions.

Health

Is rcd3 a Shetland Sheepdog condition?

It was characterised in the Cardigan Welsh Corgi. Check whether your laboratory flags it as breed-relevant for Shelties before acting on it.

Health

Can a DNA panel replace an eye examination?

No. A panel predicts genotype; an ophthalmologist observes the actual eye. For your individual dog's vision, the examination is what matters.

Costs

How much do these panels cost?

Broad commercial panels typically run around a hundred to two hundred dollars, while single targeted tests such as MDR1 cost considerably less.

Health

Should carriers be removed from breeding?

Usually not. Pair carriers with clears, test the puppies, and tell buyers. Eliminating all carriers narrows a breed's gene pool unnecessarily.

Related DogBreedCompass guides

  • progressive retinal atrophy in SheltiesWhat progressive retinal degeneration actually looks like in an affected dog.
  • Collie Eye Anomaly in Shetland SheepdogsThe breed's genuinely documented inherited eye condition and its screening.
  • MDR1 drug sensitivity in SheltiesThe one DNA test every Sheltie owner should have on file.
  • myotonia congenita and panel noiseThe same interpretation problem applied to a muscle condition from another breed.
  • Shetland Sheepdog breed guideFull breed profile listing the conditions actually documented in Shelties.
  • Shetland Sheepdog cost breakdownGenetic testing is part of the first-year cost of a responsibly bought puppy.

Bring the right questions to the vet

A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.

You get: Vet visit prep sheet

No spam. One-click unsubscribe. See our privacy policy.

Preview page 1 before you decide.

Related guides